A detailed history of Fernwood Investment Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 2,760 shares of BIIB stock, worth $441,130. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,760
Previous 2,880 4.17%
Holding current value
$441,130
Previous $667,000 19.94%
% of portfolio
0.18%
Previous 0.21%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$189.07 - $236.8 $22,688 - $28,416
-120 Reduced 4.17%
2,760 $534,000
Q2 2024

Jul 31, 2024

SELL
$190.52 - $236.72 $571 - $710
-3 Reduced 0.1%
2,880 $667,000
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $636 - $803
3 Added 0.1%
2,883 $621,000
Q3 2023

Nov 08, 2023

SELL
$253.3 - $285.89 $50,660 - $57,178
-200 Reduced 6.49%
2,880 $740,000
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $27,525 - $31,806
-100 Reduced 3.14%
3,080 $877,000
Q1 2023

May 01, 2023

SELL
$256.56 - $292.34 $320,700 - $365,424
-1,250 Reduced 28.22%
3,180 $884,000
Q4 2022

Feb 07, 2023

SELL
$252.44 - $306.72 $100,976 - $122,688
-400 Reduced 8.28%
4,430 $1.23 Million
Q3 2022

Nov 09, 2022

SELL
$194.69 - $268.46 $40,690 - $56,108
-209 Reduced 4.15%
4,830 $1.29 Million
Q1 2022

May 03, 2022

SELL
$193.77 - $244.14 $41,660 - $52,490
-215 Reduced 4.09%
5,039 $1.06 Million
Q4 2021

Feb 09, 2022

BUY
$223.92 - $287.77 $2,015 - $2,589
9 Added 0.17%
5,254 $1.26 Million
Q3 2021

Oct 28, 2021

SELL
$282.99 - $369.05 $4,244 - $5,535
-15 Reduced 0.29%
5,245 $1.48 Million
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $58,275 - $93,309
-225 Reduced 4.1%
5,260 $1.82 Million
Q1 2021

May 06, 2021

SELL
$242.95 - $284.63 $18,221 - $21,347
-75 Reduced 1.35%
5,485 $1.53 Million
Q3 2020

Nov 03, 2020

SELL
$264.77 - $305.71 $317,724 - $366,852
-1,200 Reduced 17.75%
5,560 $1.58 Million
Q1 2020

Apr 30, 2020

SELL
$268.85 - $341.04 $327,997 - $416,068
-1,220 Reduced 15.29%
6,760 $2.14 Million
Q4 2019

Feb 10, 2020

SELL
$220.06 - $304.07 $39,610 - $54,732
-180 Reduced 2.21%
7,980 $2.37 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $81,540 - $91,455
375 Added 4.82%
8,160 $1.9 Million
Q2 2019

Aug 01, 2019

SELL
$219.29 - $241.72 $257,665 - $284,021
-1,175 Reduced 13.11%
7,785 $1.82 Million
Q1 2019

May 06, 2019

SELL
$216.71 - $338.96 $5,417 - $8,474
-25 Reduced 0.28%
8,960 $2.12 Million
Q4 2018

Feb 12, 2019

SELL
$278.5 - $352.75 $13,925 - $17,637
-50 Reduced 0.55%
8,985 $2.7 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $11,740 - $15,353
-40 Reduced 0.44%
9,035 $3.19 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $25,752 - $30,691
-100 Reduced 1.09%
9,075 $2.63 Million
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $130,065 - $183,955
-500 Reduced 5.17%
9,175 $2.51 Million
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $69,219 - $77,530
-225 Reduced 2.27%
9,675 $3.08 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $2.78 Million - $3.26 Million
9,900
9,900 $3.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fernwood Investment Management, LLC Portfolio

Follow Fernwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.